Foreign Institutional Investors (FIIs) have raised shareholding in Dr Reddy's Laboratories, an integrated global pharmaceutical company.

FIIs shareholding increased 95 basis points to 34.30% at the end of March 2014 quarter from 33.35% as on Dec. 31, 2013.

On the other hand, domestic institutional investors' (DIIs) shareholding went down to 6.29% at the end of March 2014 quarter from 7.54% as on Dec. 31, 2013.

Under DIIs, mutual funds / UTI held maximum stake of 4.89%, followed by insurance companies (1.34 % stake) and Financial Institutions / Banks (0.06 stake).

Meanwhile, promoter and promoter group shareholding was unchanged at 25.52% at the end of March 2014 quarter.

Shares of the company gained Rs 16.65, or 0.66%, to settle at Rs 2,556. The total volume of shares traded was 15,558 at the BSE (Thursday).